CDI Global

Webinar: Opportunities and Investment Trends in Healthcare – 2021

While economic uncertainty is still high, certain areas in healthcare continue to show promising growth. With 2021 fast approaching, investors are expected to keep a close eye on the rapidly evolving opportunities centered around eHealth, including remote-care (telehealth), healthcare AI, IoT Technology, and the platforms to capture patient data remotely and securely. 

These opportunities are not without risk. Investors need to determine which trends are more short lived and likely to diminish post-pandemic and which areas are more likely to scale, both from a demand and operational perspective. These considerations must also take the ever-changing PR landscape around PE healthcare into account. 

Join experts Dr. Gary Epler (Associate Professor of Medicine at the Harvard Medical School, and Managing Director, Gracewater Capital), Troy Crabtree (founder of Navita), and Michael Buchanio (Senior Principal, Healthcare & Life Sciences Chicago) for an in-depth discussion on Post-Pandemic Healthcare Opportunities and Investment trends in 2021. 

Topics discussed during the webinar include:

  • Post-Pandemic investment trends in healthcare
  • The direction of specialty pharmacy and molecular diagnostics post-pandemic
  • Staying ahead with defensive PR on the private equity front
  • How Healthcare AI is reshaping the healthcare industry
  • Market implications for updated CMS reimbursement rules on RPM service


Participation is free and all are welcome to attend. Webinar takes place January 12, 2021, 2pm-3pm Eastern Standard Time. 

Stay tuned for ways to stay connected and network after this event!

Register here!

Connect with a CDI Expert. Request a Call Back.

News & Insights

Read more

June 9, 2021

CDI Global Italy Advises Axioma on Acquisition by Zucchetti

Read more

June 7, 2021

The State of the Healthcare Sector M&A Market

1
Insights into M & A in the Energy Sector
2
CDI Global Brazil Advises DTM on Acquisition by Plusoft
3
The Personal Care Ingredients Sector Remains Ripe for Consolidation